PURA VIDA INVESTMENTS, LLC
Long book
$14.9M
Q1 2026
Positions
17
Top-10 weight
87%
concentration
Last quarter
+40.6%
SPY +14.8%
Turnover
6%
of book per quarter
Strategy in plain words
auto-generated from filingsPURA VIDA INVESTMENTS, LLC is a concentrated fundamental stock-picker, running a $14.9M US long book across 17 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The book barely moves quarter to quarter — a patient, low-turnover holder. Current anchor positions: INSIGHT MOLECULAR DIAGNOSTIC, BETA BIONICS INC, ESTABLISHMENT LABS HOLDINGS, CARIS LIFE SCIENCES INC, INSPIREMD INC.
Over the last 9 quarters its long book ran on average 0.5pp per quarter ahead of the S&P 500, beating the index in 4 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-4.3%
Q2 2024
+8.6%
Q3 2024
-8.8%
Q4 2024
-15.2%
Q1 2025
+8.8%
Q2 2025
+16.4%
Q3 2025
+42.8%
Q4 2025
-43.6%
Q1 2026
+40.6%
Sector allocation
Healthcare 60%
Materials 23%
Technology 12%
Financials 3%
Industrials 2%
Consumer discretionary 2%
Long book by quarter
What does PURA VIDA own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| IMDX INSIGHT MOLECULAR DIAGNOSTIC | Materials | 947.1K | $3.1M | 20.9% | Held |
| BBNX BETA BIONICS INC | Healthcare | 281.3K | $2.8M | 18.9% | Held |
| ESTA ESTABLISHMENT LABS HOLDINGS | Healthcare | 45.0K | $2.6M | 17.2% | Held |
| CAI CARIS LIFE SCIENCES INC | Healthcare | 89.9K | $1.6M | 10.8% | Held |
| NSPR INSPIREMD INC | Healthcare | 450.5K | $734K | 4.9% | Held |
| NTRA NATERA INC | Healthcare | 2.5K | $500K | 3.4% | Held |
| NVDA NVIDIA CORP | Technology | 2.5K | $436K | 2.9% | +7.3% |
| JPM JPMORGAN CHASE & CO | Financials | 1.4K | $397K | 2.7% | Held |
| MSFT MICROSOFT CORP | Technology | 990 | $366K | 2.5% | -17.5% |
| MGX METAGENOMI THERAPEUTICS INC | Healthcare | 264.4K | $354K | 2.4% | Held |
| GOOG ALPHABET INC-CL C | Technology | 1.2K | $341K | 2.3% | Held |
| OM OUTSET MEDICAL INC | Healthcare | 83.3K | $320K | 2.2% | +1566.7% |
| ADI ANALOG DEVICES INC | Technology | 1.0K | $318K | 2.1% | Held |
| AAPL APPLE INC | Technology | 1.2K | $296K | 2.0% | Held |
| ASML ASML HOLDING NV-NY REG SHS | Industrials | 190 | $251K | 1.7% | Held |
| LIN LINDE PLC | Materials | 500 | $248K | 1.7% | Held |
| AMZN AMAZON.COM INC | Consumer discretionary | 1.1K | $229K | 1.5% | +10.0% |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 12, 2026 | 17 | $14.9M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 13, 2026 | 19 | $26.8M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 12, 2025 | 8 | $16.4M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 13, 2025 | 9 | $16.6M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 12, 2025 | 8 | $13.7M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 12, 2025 | 19 | $31.6M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 14, 2024 | 42 | $153.4M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 14, 2024 | 49 | $158.0M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 15, 2024 | 51 | $593.3M | canonical | SEC ↗ |
Similar funds
Sanders Capital, LLCGATES FOUNDATION TRUSTEAGLE CAPITAL MANAGEMENT LLCWoodbridge Co LtdAlecta Tjanstepension OmsesidigtMubadala Investment Co PJSCH&H International Investment, LLCNewlands Management Operations LLCINVESTOR ABIndependent Franchise Partners LLPPineStone Asset Management Inc.Pentwater Capital Management LP